The FDA is considering a rule change that would cut back on how often dietary supplement warnings must appear on packaging, a move experts say could make them easier to miss.

The FDA is considering a change to reduce how often warnings and health disclaimers appear on dietary supplement labels.

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.

America is in the midst of a pharmacy crisis, and the Food and Drug Administration could make it much worse. Hundreds of ...

Project Renewal updates older oncology drug labels to ensure clinical relevance and scientific accuracy, involving external experts and early-career scientists. Fludarabine phosphate's updated label ...

Agios Pharmaceuticals AGIO announced that the FDA has approved Aqvesme (mitapivat) for the treatment of adult patients with ...

Black box warnings are the FDA’s bluntest regulatory instrument short of a recall. Yet despite what headlines, pundits, and influencers often suggest, they are neither a moral verdict nor the final ...

Please provide your email address to receive an email when new articles are posted on . The FDA has updated the label for Ozempic to include the potential risk for ileus, or an intestinal blockage, as ...

The first-of-its-kind app to help you find out where your generic drugs come from and see the track records of the factories ...

The hugely popular weight loss agent semaglutide (approved as Wegovy for weight loss; Ozempic for type 2 diabetes; Novo Nordisk) received a pair of drug safety–related labeling additions from the US ...